{
    "title": "Anti-Muscarinic agents",
    "type": "dcq",
    "author": "ayobami",
    "course": "pharmacology",
    "date": "2024-06-14 14:27",
    "description": "reviewing anti-muscarinic agents?",
    "difficulty": "medium",
    "questions": [
        {
            "question": "scopalamine causes strong vasoconstriction of the blood vessels",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "B is indicated for motion sickness",
            "answer": "true"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "C is indicated for motion sickness",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "E is administered intravenously",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "E helps in reducing or preventing bronchospasms",
            "answer": "true"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "E is administered nasally",
            "answer": "true"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "C is indicated for COPD",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "C is indicated for urinary incontinence",
            "answer": "true"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "A is indicated for nicotinic toxicity",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "A is indicated for organophosphate poisoning",
            "answer": "true"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "D can regenerate AcetylCholinesterase after aging",
            "answer": "false"
        },
        {
            "text": "Atropine (A), Scopolamine (B), Oxybutynin (C), Pralidoxime (D), Ipratropium (E)",
            "question": "A + D are indicated for cholinergic toxicity",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "mydriasis",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "cycloplegia",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "reduced gastrointestinal motility and secretion",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "reduced urinary motility",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "bronchodilation",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "reduced secretions",
            "answer": "true"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "cyclospasm",
            "answer": "false"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "miosis",
            "answer": "false"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "increased gastrointestinal motility",
            "answer": "false"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "urinary hypermotility",
            "answer": "false"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "bronchoconstriction",
            "answer": "false"
        },
        {
            "text": "effects of antimuscarinic agents",
            "question": "increased secretions",
            "answer": "false"
        }
    ]
}
